Among Bcl-2 family proteins, Bcl-xL has emerged as a multifaceted factor that plays a pivotal role in the progression of different kinds of cancer, including melanoma, acting at different stages as initiation, invasion, metastasis, and acquisition of chemo-resistance. This evidence concerns the gene BCL2L1 and cancer.